Literature DB >> 7377816

Serum ferritin, liver iron stores, and liver histology in children with thalassaemia.

S de Virgiliis, G Sanna, G Cornacchia, F Argiolu, V Murgia, M Porcu, A Cao.   

Abstract

Serum ferritin, liver iron stores, and liver histology were studied in 38 children with thalassaemia major who were being treated by regular blood transfusions. There was no correlation between serum ferritin levels and either the number of transfusions or the amount of iron deposited in the liver. However, for a given level of iron stores, ferritin levels were higher in patients with chronic hepatitis (including chronic aggressive and chronic persistent forms) than in those with hepatic siderosis only. We conclude that serum ferritin reflects tissue iron deposits in regularly transfused thalassaemic patients, only in the absence of hepatitis.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7377816      PMCID: PMC1626725          DOI: 10.1136/adc.55.1.43

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  13 in total

Review 1.  Serum ferritin and iron stores.

Authors:  A Jacobs
Journal:  Fed Proc       Date:  1977-06

2.  A classification of chronic hepatitis.

Authors:  J De Groote; V J Desmet; P Gedigk; G Korb; H Popper; H Poulsen; P J Scheuer; M Schmid; H Thaler; E Uehlinger
Journal:  Lancet       Date:  1968-09-14       Impact factor: 79.321

3.  Measurement of serum ferritin by a 2-site immunoradiometric assay.

Authors:  L E Miles; D A Lipschitz; C P Bieber; J D Cook
Journal:  Anal Biochem       Date:  1974-09       Impact factor: 3.365

4.  A clinical evaluation of serum ferritin as an index of iron stores.

Authors:  D A Lipschitz; J D Cook; C A Finch
Journal:  N Engl J Med       Date:  1974-05-30       Impact factor: 91.245

5.  Serum ferritin in patients with iron overload and with acute and chronic liver diseases.

Authors:  J Prieto; M Barry; S Sherlock
Journal:  Gastroenterology       Date:  1975-03       Impact factor: 22.682

6.  Role of chronic hepatitis in development of thalassaemic liver disease.

Authors:  G Masera; G Jean; G Gazzola; M Novakova
Journal:  Arch Dis Child       Date:  1976-09       Impact factor: 3.791

7.  Globin chain synthesis in the alpha thalassemia syndromes.

Authors:  Y W Kan; E Schwartz; D G Nathan
Journal:  J Clin Invest       Date:  1969-11       Impact factor: 14.808

8.  An immunoradiometric assay for ferritin in the serum of normal subjects and patients with iron deficiency and iron overload.

Authors:  G M Addison; M R Beamish; C N Hales; M Hodgkins; A Jacobs; P Llewellin
Journal:  J Clin Pathol       Date:  1972-04       Impact factor: 3.411

9.  Serum ferritin in children with thalassaemia regularly transfused.

Authors:  E A Letsky; F Miller; M Worwood; D M Flynn
Journal:  J Clin Pathol       Date:  1974-08       Impact factor: 3.411

10.  Ferritin in the serum of normal subjects and patients with iron deficiency and iron overload.

Authors:  A Jacobs; F Miller; M Worwood; M R Beamish; C A Wardrop
Journal:  Br Med J       Date:  1972-10-28
View more
  7 in total

Review 1.  Magnetic resonance imaging measurement of iron overload.

Authors:  John C Wood
Journal:  Curr Opin Hematol       Date:  2007-05       Impact factor: 3.284

2.  Hepatitis B virus infection in thalassemia major.

Authors:  V Larcher; P Habibi; E Price
Journal:  Br Med J (Clin Res Ed)       Date:  1984-08-25

3.  Primary hypothyroidism and the low T3 syndrome in thalassaemia major.

Authors:  A R Sabato; V de Sanctis; G Atti; L Capra; B Bagni; C Vullo
Journal:  Arch Dis Child       Date:  1983-02       Impact factor: 3.791

Review 4.  The Evaluation of Iron Deficiency and Iron Overload

Authors:  Norbert Gattermann; Martina U Muckenthaler; Andreas E Kulozik; Georgia Metzgeroth; Jan Hastka
Journal:  Dtsch Arztebl Int       Date:  2021-12-10       Impact factor: 5.594

5.  Intravenous and subcutaneous desferrioxamine therapy in children with severe iron overload.

Authors:  G E Janka; P Möhring; M Helmig; R J Haas; K Betke
Journal:  Eur J Pediatr       Date:  1981-11       Impact factor: 3.183

6.  Longitudinal Study on Liver Functions in Patients with Thalassemia Major before and after Deferasirox (DFX) Therapy.

Authors:  Ashraf Soliman; Mohamed Yassin; Fawzia Al Yafei; Lolwa Al-Naimi; Noora Almarri; Aml Sabt; Vincenzo De Sanctis
Journal:  Mediterr J Hematol Infect Dis       Date:  2014-04-07       Impact factor: 2.576

7.  Korean guideline for iron chelation therapy in transfusion-induced iron overload.

Authors:  Jun Ho Jang; Je-Hwan Lee; Sung-Soo Yoon; Deog-Yeon Jo; Hyeoung-Joon Kim; Jooseop Chung; Jong Wook Lee
Journal:  J Korean Med Sci       Date:  2013-10-31       Impact factor: 2.153

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.